CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension.
about
Caffeine: cognitive and physical performance enhancer or psychoactive drug?The impact of coffee consumption on blood pressure, cardiovascular disease and diabetes mellitus.Addressing the inter-individual variation in response to consumption of plant food bioactives: Towards a better understanding of their role in healthy aging and cardiometabolic risk reduction.Caffeine and blood pressure response: sex, age, and hormonal status.Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.Disclosure of genetic information and change in dietary intake: a randomized controlled trial.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Espresso coffee consumption and risk of coronary heart disease in a large Italian cohortA randomized trial of genetic information for personalized nutritionGenome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAMStudy Frequency of Hypertension and Obesity and their Relationship with Lifestyle Factors (Nutritional Habits, Physical Activity, Cigarette Consumption) in Ardabil City Physicians, 2012-13.The role of nutrition and nutraceutical supplements in the treatment of hypertensionEffects of tea and coffee on cardiovascular disease risk.Considering CYP1A2 phenotype and genotype for optimizing the dose of olanzapine in the management of schizophrenia.Coffee consumption and cardiovascular health: getting to the heart of the matter.Nutrition and nutraceutical supplements for the treatment of hypertension: part III.Effect of taurine and potential interactions with caffeine on cardiovascular function.Are the Current Guidelines on Caffeine Use in Sport Optimal for Everyone? Inter-individual Variation in Caffeine Ergogenicity, and a Move Towards Personalised Sports Nutrition.Interindividual Variability in Biomarkers of Cardiometabolic Health after Consumption of Major Plant-Food Bioactive Compounds and the Determinants Involved.Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients.Precision Nutrition: A Review of Personalized Nutritional Approaches for the Prevention and Management of Metabolic Syndrome.The genetic profiles of CYP1A1, CYP1A2 and CYP2E1 enzymes as susceptibility factor in xenobiotic toxicity in Turkish population.Caffeine Use Disorder: A Comprehensive Review and Research Agenda.Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes.Energy drink consumption and impact on caffeine risk.Scientific Opinion on the safety of caffeinePriority topics for the development of risk assessment guidance by EFSA's Scientific Committee in 2016–2018A scheme for a flexible classification of dietary and health biomarkers.CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions.Cocktail approach for in vivo phenotyping of 5 major CYP450 isoenzymes: development of an effective sampling, extraction, and analytical procedure and pilot study with comparative genotyping.The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease.Recent Science and Clinical Application of Nutrition to Coronary Heart Disease.Coffee consumption and risk of hypertension: a systematic review and dose-response meta-analysis of cohort studies.Influence of a CYP1A2 polymorphism on post-exercise heart rate variability in response to caffeine intake: a double-blind, placebo-controlled trial.Guide for Current Nutrigenetic, Nutrigenomic, and Nutriepigenetic Approaches for Precision Nutrition Involving the Prevention and Management of Chronic Diseases Associated with Obesity.Do Coffee Polyphenols Have a Preventive Action on Metabolic Syndrome Associated Endothelial Dysfunctions? An Assessment of the Current Evidence.High Coffee Intake, but Not Caffeine, is Associated with Reduced Estrogen Receptor Negative and Postmenopausal Breast Cancer Risk with No Effect Modification by CYP1A2 Genotype
P2860
Q28080581-EF7EF49F-8BCD-440C-8AAF-3C2F8BB4F6CBQ30238756-6D8A29FF-F037-4EFC-B003-734636F2FFC3Q30244987-75715FA0-8289-49B5-ABFC-A216DEBDBD42Q34132144-E9C5762C-FC75-4656-A1B0-C1E608E5719FQ34307589-03004239-5019-4FA6-A036-BA55ADEDAA26Q34513835-24D9C98F-38AF-4F15-88DA-530296BB5D6CQ35015993-52184BCF-4C1D-4005-A78F-91DE9C3281A7Q35577594-F9EA8ED6-96D1-4DD1-A1E6-7B1ABA62233DQ36250140-34545A55-6E03-450D-B362-C957182EA1A6Q36352038-8B9735DB-E925-4095-B5A2-2CE8E3F2F389Q37419779-5F10EF87-2C8D-47F6-B01A-2E1EBE07A03EQ37603725-21240B8B-F267-4772-B1BE-E96580138158Q37997941-04DAE4A6-CCAE-4F78-936B-6B9248E82F1FQ38103885-41930ACF-82F4-48C6-9FA5-0AEF33F09E47Q38132704-4B97792E-4BA5-436A-B398-D73EC19F1FFBQ38151983-262F0D7F-A07E-44A8-94B3-8CEEBBE15CF7Q38194933-93A7EE4A-C1AD-4B8A-957B-92A0F7869D18Q38635751-77456FDA-0916-4474-9E54-3BC92BFDD686Q39436135-94DE95E9-7179-4C8C-8462-79F9608F2B6EQ41572724-75D8CB03-C1E8-4729-BBA4-2BC83500443AQ41584472-5D4CB05D-BD38-4203-BDDF-CAEF0FEAED34Q41884128-6ED3F626-0182-4705-B729-0E757F054F41Q42636888-BC9E45A5-CEF5-4E60-A29C-7FACF6CBA3E5Q46523360-AA8D8BDF-CD50-42C3-BE30-3BB238C61F9FQ46687608-1E56BA23-14B2-4BE2-8F72-F2EA04E382AFQ47156955-ECC5DD84-BD1C-4AD8-B058-464BBB66CFC6Q47157836-F5980E3E-098F-4262-A2E0-3597B33813C1Q47168781-CA9575A5-3C0F-4E3C-8F0E-DEF7E69713E5Q47998145-3FB58205-CFA0-4163-9565-9C8F0C3A8501Q48234146-ECB0F3D0-8C42-474F-A06B-7166ED2C6E14Q50115527-C0396CA0-DDF4-46CD-94A8-A4C73E39FB24Q50126071-996DB4C1-8388-4D6F-99DB-89EF4C81690EQ50185988-83B018B3-4219-4380-8A34-405EE800D70EQ51671872-3EFF81E1-BA7E-4610-8AA0-CD97CAC0671EQ53173083-45917197-3934-4F20-89E3-A8B1E1349EC2Q55104724-E9254283-7D0F-4C48-A33F-229407AA0F39Q59150888-A9DD54EA-D336-498E-96CD-A509F7FEF585
P2860
CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
CYP1A2 genotype modifies the a ...... and the risk of hypertension.
@en
CYP1A2 genotype modifies the a ...... and the risk of hypertension.
@nl
type
label
CYP1A2 genotype modifies the a ...... and the risk of hypertension.
@en
CYP1A2 genotype modifies the a ...... and the risk of hypertension.
@nl
prefLabel
CYP1A2 genotype modifies the a ...... and the risk of hypertension.
@en
CYP1A2 genotype modifies the a ...... and the risk of hypertension.
@nl
P2093
P1476
CYP1A2 genotype modifies the a ...... e and the risk of hypertension
@en
P2093
Fabio Ragazzo
Francesca Dorigatti
Giuseppe Zanata
Italia Papparella
Massimo Santonastaso
Paolo Palatini
P304
P356
10.1097/HJH.0B013E32832BA850
P577
2009-08-01T00:00:00Z